308 results on '"Hayeems, Robin Z."'
Search Results
52. Genome sequencing for detection of pathogenic deep intronic variation: A clinical case report illustrating opportunities and challenges
53. Newborn screening for cystic fibrosis
54. Primary care providers’ role in newborn screening result notification for cystic fibrosis
55. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting
56. Incorporating Cascade Effects of Genetic Testing in Economic Evaluation: A Scoping Review of Methodological Challenges
57. Informing parents about expanded newborn screening: influences on provider involvement
58. Questioning the consensus: managing carrier status results generated by newborn screening
59. Genome sequencing among children with medical complexity: What constitutes value from parents' perspective?
60. Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review
61. Policy Rogue or Policy Entrepreneur? The Forms and Impacts of “Joined-Up Governance” for Child Health
62. Measuring clinical utility in the context of genetic testing: a scoping review
63. Genome Sequencing as a Diagnostic Test in Children With Unexplained Medical Complexity
64. Expanding Clinical Presentations Due to Variations in THOC2 mRNA Nuclear Export Factor
65. Genome Diagnostics: Novel Strategies for Measuring Value
66. CARRIER DETECTION AND CLINICAL UNCERTAINTY: THE CASE FOR PUBLIC HEALTH ETHICS
67. Hour-Specific Total Serum Bilirubin Percentiles for Infants Born at 29–35 Weeks' Gestation.
68. Transcutaneous versus Total Serum Bilirubin Measurements in Preterm Infants.
69. Clinical utility of genomic sequencing: a measurement toolkit.
70. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
71. Genome-wide sequencing technologies: A primer for paediatricians
72. False-Positive Newborn Screening for Cystic Fibrosis and Health Care Use
73. Managing sickle cell carrier results generated through newborn screening in Ontario: a precedent-setting policy story
74. A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis
75. Parent Experience With False-Positive Newborn Screening Results for Cystic Fibrosis
76. Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options
77. Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine
78. MG-108 Beyond the ACMG 56: Parental choices and initial results from a comprehensive whole genome sequencing-based search for predictive genomic variants in children
79. MG-132 Diagnostic utility of whole genome sequencing in paediatric medicine
80. Genome-wide sequencing technologies: A primer for paediatricians.
81. What's Involved with Wanting to Be Involved? Comparing Expectations for Public Engagement in Health Policy across Research and Care Contexts.
82. Public Perceptions of the Benefits and Risks of Newborn Screening
83. Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray
84. Parent attitudes to newborn screening consent practices
85. In the loop: Primary care providers' role in newborn screening for cystic fibrosis
86. How does learning false positive results through newborn screening for cystic fibrosis influence cascade testing and family planning?
87. Making sense of diagnostic uncertainty after newborn screening for cystic fibrosis
88. Experiences of caregivers of children with inherited metabolic diseases: a qualitative study.
89. Puberty and Schizophrenia Onset
90. Public views on participating in newborn screening using genome sequencing
91. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care
92. Expectations and values about expanded newborn screening: a public engagement study
93. Citizens’ Values Regarding Research With Stored Samples From Newborn Screening in Canada
94. Health-care providers’ views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders
95. Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening
96. Understanding sickle cell carrier status identified through newborn screening: a qualitative study
97. The expansion of newborn screening: is reproductive benefit an appropriate pursuit?
98. Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray.
99. Rates of prenatal screening across health care regions in Ontario, Canada: a retrospective cohort study.
100. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.